Zi-Han Liu

Zi-Han Liu

Auto-generated profile, based on publicly available information

Zi-Han Liu

Graduate School, Beijing University of Chinese Medicine, Beijing, 100029, China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2026 in Journal of Autoimmunity
Verified
Journal Article
Closed access
BTBojie Tang
Bojie Tang
YZYan Zhang
Yan Zhang
XYXinbo Yu
Xinbo Yu
CLChunxin Lei
Chunxin Lei
JCJiaqi Chen
Jiaqi Chen
JLJing Luo
Jing Luo

11 May 2026 in Lipids in Health and Disease
Verified
Journal Article
Open access
XZXuan-Yi Zhou
Xuan-Yi Zhou
YZYan Zhang
Yan Zhang
CLChun-Xin Lei
Chun-Xin Lei
ZLZi-Han Liu
Zi-Han Liu
JCJia-Qi Chen
Jia-Qi Chen
JLJing Luo
Jing Luo
Primary Sjögren's disease (pSjD) confers a markedly elevated risk for developing CVD, an important contributor to mortality in this population. This study was designed to identify factors associated with CVD in pSjD and to develop a classification model. In this cross-sectional analysis of pSjD individuals (2013-2023), multivariable logistic regression was used to identify CVD-related factors. A classification model was constructed with variable selection via LASSO regression and the Boruta algorithm. Among 734 patients with pSjD, 192 (26.2%) had CVD. Age (odds ratio [OR]: 1.06, P < 0.001), body mass index (BMI; OR: 1.14, P < 0.001), triglyceride-glucose (TyG) index (OR: 3.49, P < 0.001), and positive anti-Ro52 status (OR: 1.58, P = 0.022) were independent correlates of CVD in pSjD. Moreover, age, BMI, and TyG index showed a trend of gradually increasing CVD risk in patients with pSjD (P < 0.05). A five-variable classification model incorporating age, BMI, TyG index, anti-Ro52 antibody, and corrected QT interval was developed to identify CVD status. Good discrimination (area under the curve: 0.768), proper calibration, and clinical applicability were observed for this model. Its performance remained robust upon internal validation and testing in the test set (area under the curve: 0.753 and 0.821). The TyG index and anti-Ro52 antibody serve as significant factors associated with prevalent CVD in patients with pSjD. A novel classification model that integrates these biomarkers with age, BMI, and corrected QT interval showed good performance and generalizability, and may provide a practical tool for identifying cardiovascular status in this population.